Posts tagged Pedro Martinez-Clark
Dr. Martinez-Clark's Miami MedTech Incubator Gains Traction

MMT is the first comprehensive healthcare incubator in South Florida that is dedicated to medical device innovation and works to develop products that will make a real impact on people’s lives. The incubator wouldn’t have been possible without Dr. Pedro Martinez-Clark, a renowned Harvard-trained interventional cardiologist who goes above and beyond the call of duty. Dr. Martinez-Clark became involved in medical innovation during his fellowship in Boston and pursued his passion after relocating to South Florida.

Read More
Miami MedTech —Dr. Pedro Martinez-Clark's initiative to create a medical innovation ecosystem in South Florida— received the first Lifees Award at eMerge Americas 2016

The Lifees are a way of honoring those companies that are helping to transform South Florida into a life sciences epicenter. The Miami MedTech initiative —co-founded by Dr. Pedro Martinez-Clark and Max Mendez— is Interventional Concepts' product development initiative in Miami that allows local (and Latin American) innovators to fulfill their dreams of bringing new medical technologies with global impact to market.  

Read More
Colombia's Keraderm and Interventional Concepts join forces for a first-in-human trial to validate a technology to remodel and reconstruct skin tissue

Keraderm, an innovative product to heal skin defects based on cultures of keratinocytes and fibroblasts, developed in Colombia by Dr. Rodrigo Soto, Jennifer Gaona and Juan Zambrano, has joined forces with Interventional Concepts to design and manage a clinical study in humans. The study results will allow the product to be approved for commercialization by Colombia's Invima and other international regulatory bodies as a requirement for global expansion.

Read More
Keraderm e Interventional Concepts se alían para un estudio de investigación clínica en humanos que permitirá validar una novedosa tecnología para remodelación y reconstrucción de tejidos de piel

Keraderm, un novedoso producto para el cubrimiento de defectos de la piel basado en cultivos de queratinocitos y fibroblastos, desarrollado en Colombia por los doctores Rodrigo Soto, Jennifer Gaona, Juan Zambrano y Jorge Luis Gaviria, confía en Interventional Concepts para diseñar y administrar un estudio clínico en humanos, cuyos rigurosos resultados permitirán que el producto sea validado por el Invima, así como otras entidades regulatorias internacionales como requisito para su comercialización global.

Read More
Colombian leading ophthalmologist and Interventional Concepts joined forces to develop an innovative medical device for cataract surgeries

Clínica Oftalmológica del Caribe (COFCA), located in Barranquilla, Colombia, has received funding from Colombia's Administrative Department of Science, Technology and Innovation (COLCIENCIAS) to develop an injection system of viscoelastic substances during cataract surgery invented and patented by Dr. Luis Escaf, its founder and medical director. Ophthalmology experts agree that the quality and number of corneal endothelial cells decrease after intraocular surgery, especially during cataract phacoemulsification. The good health of the eye's endothelium ensures that the cornea is transparent and healthy. If the cornea is not transparent after cataract surgery, the patient's vision is impaired, so specialists need to perform a corneal transplant or transplant corneal endothelium to the damaged eye. Dr. Luis Escaf's device prevents the damage to the eye during cataract surgery. The prototype is being developed by Interventional Concepts' bioengineering team in Miami, FL. The project will be led by Dr. Pedro Martinez-Clark, a Colombian-born physician with extensive medical device development track record in the US. 

Read More
La Clínica Oftalmológica del Caribe se alía con Interventional Concepts para desarrollar novedoso sistema para cirugías de catarata

La Clínica Oftalmológica del Caribe (COFCA) ha recibido fondos de Colciencias bajo la convocatoria Locomotora de la Innovación para Empresas para desarrollar un sistema de inyección de sustancias viscoelásticas durante la cirugía de catarata. La idea de este sistema de inyección surge como respuesta a los daños que sufre el ojo durante las cirugías intraoculares. Según especialistas en esta rama, la calidad y el número de células del endotelio corneal disminuye luego de una cirugía, en especial de la de catarata con técnica de facoemulsificación. Esto es crucial para la salud, pues el buen estado del endotelio garantiza que la córnea esté transparente y sana. Si la córnea no está transparente, la visión se compromete y el paciente no puede ver, por lo que hay que realizar un trasplante de córnea o un trasplante de endotelio corneal. El sistema ideado y patentado por el Dr. Luis Escaf —fundador y director médico de COFCA— evita los daños que sufre el ojo durante la cirugía de catarata. El prototipo del sistema está siendo desarrollado en el laboratorio de bioingeniería de Interventional Concepts en Miami, FL —una empresa dedicada al desarrollo de innovaciones en ciencias de salud. Ambas empresas, conscientes de la importancia de estar a la vanguardia de la investigación e innovación en ciencias de la vida, han unido esfuerzos para desarrollar este sistema como antesala a su comercialización global.

Read More
Dr. Pedro Martinez-Clark presented our proposed Colombia Life Sciences Initiative to the Colombian Ambassador to the United States —Colombia will be Latin America's life sciences innovation star

Colombia's vision by 2025 is to become one of the top three innovative countries in Latin America by promoting human capital for the knowledge economy, research and development (R&D) and innovation; and by raising awareness of science, technology and innovation in the Colombian society. The initiative seeks to attract foreign innovative life sciences startups to Colombia by offering them R&D funding and a generous 175% capital allocation tax deduction —among other incentives. 

Read More
Dr. Pedro Martinez-Clark —a renowned Harvard-trained Colombian cardiologist— receives funding to develop and market an innovative medical device based on the revolutionary TransCaval Access technique

Dr. Pedro Martinez-Clark, a renowned interventional cardiologist trained at Harvard, is developing an innovative medical device based on the revolutionary TransCaval Access (TCA) technique —co-developed with his research group in Cali, Colombia—, to treat patients with severely clogged arteries. The technique won the Best of the Best Abstract Award at The Society for Cardiovascular Angiography and Interventions (SCAI)'s 2014 meeting. Dr. Martinez-Clark obtained funding from private investors to develop and market his medical device to treat over 154,000 patients annually who can not be treated with conventional technical devices, thus creating a $ 2.2 billion market opportunity in 2020.

Read More
Pedro Martinez-Clark, reconocido cardiólogo colombiano, recibe fondos millonarios para desarrollar y comercializar su innovador dispositivo médico basado en la ingeniosa técnica TransCaval Access

Pedro Martinez-Clark, reconocido cardiólogo colombiano graduado de Harvard, recibe fondos millonarios para desarrollar y comercializar dispositivos médicos basados en su ingeniosa técnica TransCaval Access (TCA).

Read More